Peptide Comparison
Apelin-13vsThymosin Beta-4
A natural heart hormone that helps your cardiovascular system work better and supports healthy blood flow throughout your body.
The body's natural healing peptide that accelerates tissue repair and reduces inflammation
At a Glance
Quick
comparison
Dose Range
Apelin-13
As prescribed–As prescribed mg
Thymosin Beta-4
2–5 mg
Frequency
Apelin-13
Once daily
Thymosin Beta-4
Twice weekly
Administration
Apelin-13
Intravenous (IV)
Thymosin Beta-4
Subcutaneous injection
Cycle Length
Apelin-13
Ongoing/indefinite
Thymosin Beta-4
8-12 weeks
Onset Speed
Apelin-13
Moderate (1-2 weeks)
Thymosin Beta-4
Moderate (1-2 weeks)
Evidence Level
Apelin-13
Moderate human trials (Phase 1-2)
Thymosin Beta-4
Moderate human trials (Phase 1-2)
Efficacy
Benefit
ratings
Cardiovascular Support
Heart Function & Strength
Blood Flow & Circulation
Wound Healing
Inflammation Reduction
Tissue Regeneration
Technical Data
Compound
specifications
Apelin-13
Molecular Formula
C69H111N23O16S
Molecular Weight
1550.8 Da
Half-Life
Minutes in plasma; varies by route of administration
Bioavailability
~90-95% (subcutaneous injection)
CAS Number
Not yet assigned (research compound)
Thymosin Beta-4
Molecular Formula
C212H350N56O78S
Molecular Weight
4963
Half-Life
Dose-dependent (increases with higher doses)
Bioavailability
100% (subcutaneous and intravenous)
CAS Number
77591-33-4
Applications
Best
suited for
Apelin-13
Research into cardiovascular health and heart function
Apelin-13 is particularly well-suited for individuals focused on research into cardiovascular health and heart function. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Understanding how the body naturally protects the heart
Apelin-13 is particularly well-suited for individuals focused on understanding how the body naturally protects the heart. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Exploring potential treatments for heart failure
Apelin-13 is particularly well-suited for individuals focused on exploring potential treatments for heart failure. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Studying mechanisms of heart muscle strength
Apelin-13 is particularly well-suited for individuals focused on studying mechanisms of heart muscle strength. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Thymosin Beta-4
Post-Surgery Recovery
Accelerates healing of surgical wounds and reduces post-operative inflammation and scarring
Chronic Wound Management
Helps pressure ulcers, venous stasis ulcers, and other slow-healing wounds progress faster
Tissue Regeneration
Supports repair of damaged tissues from injury, burns, or degenerative conditions
Safety Profile
Side
effects
Apelin-13
Common
- Mild changes in blood pressure
- Minimal systemic effects in animal studies
- Headache (theoretical, based on blood pressure effects)
- Flushing or warmth at injection site
- Mild inflammation at injection site
- Dizziness if blood pressure drops too quickly
- Allergic reactions to the peptide
- Heart rhythm changes (requires monitoring)
- Blood pressure, heart rate, cardiac function
Serious
- Severe allergic reaction
Thymosin Beta-4
Common
- Injection site redness
- Injection site swelling
Uncommon
- Temporary mild headache
- Mild bruising at injection site
- Transient fatigue
Serious
- Allergic reaction
Research Status
Safety
& evidence
Apelin-13
Evidence Level
Moderate human trials (Phase 1-2)
FDA Status
Research compound
Safety Overview
Apelin-13 is a research compound with no human clinical trials or FDA approval. All safety data comes from animal studies and in vitro mechanistic work showing beneficial effects on vascular function and cardiac remodeling. However, animal models do not predict human safety, and the peptide's effects on immune regulation in humans remain untested. No dose-ranging studies, pharmacokinetics, or organ accumulation data exist in humans. The APJ receptor is expressed in multiple tissues including brain, raising concerns about off-target neurological effects at high doses.
Contraindications
- xCurrently under investigation - not for human clinical use
- xMay interact with blood pressure medications (in theory)
- xShould not be used if allergic to peptides or component amino acids
- xPregnant or breastfeeding individuals should avoid
Thymosin Beta-4
Evidence Level
Moderate human trials (Phase 1-2)
FDA Status
Research compound
Safety Overview
Thymosin Beta-4 is a naturally occurring peptide found in all cells and body fluids in the human body. Clinical trials have demonstrated excellent safety even at very high doses. IV studies showed doses up to 1260 mg were well tolerated with no serious adverse events.
Contraindications
- xActive systemic infections
- xSevere immunosuppression
- xHypersensitivity to thymosin or any component
- xPregnancy (insufficient safety data)
Decision Guide
Which is
right for you?
Choose Apelin-13 if...
- Research into cardiovascular health and heart function
- Understanding how the body naturally protects the heart
- Exploring potential treatments for heart failure
- Studying mechanisms of heart muscle strength
Choose Thymosin Beta-4 if...
- Recovering from injuries or surgery
- Improving wound healing speed
- Reducing inflammation
- Minimizing scar formation